Saladax Biomedical, based in Bethlehem, Philadelphia, USA is a personalized medicine diagnostics company that is successfully pioneering the development and commercialization of innovative, patented immunoassays to SIMPLY and ACCURATELY MEASURE chemotherapy blood levels.
This will enable oncologists to PRECISELY ADJUST and PERSONALIZE chemotherapy dosage administered to achieve OPTIMAL systemic target blood levels. As a result, PERSONALIZED CHEMOTHERAPY MANAGEMENT (PCM) will provide oncologists with a new tool to balance EFFICACY against SIDE EFFECTS, thereby REDUCING toxicity, IMPROVING outcomes and LOWERING cancer care costs.
Saladax Biomedical has the proprietary technology (a simple blood test) that will allow oncologists to optimally dose chemotherapy drugs. Their first test is for colorectal cancer which is a leading cancer here. A clinical trial is currently being conducted here in Singapore.
For more information, please visit http://www.saladax.com. It is a very comprehensive website with results of clinical studies and other reference materials.
Saladax is seeking a distributor that can reach out to oncologists, hospital and reference laboratories that perform oncology or genetic testing. If you are interested, please respond by completing the online form below.
If you have any questions, please call or email Luanne Theseira at 6476-9416, email: Luanne.Theseira@mail.doc.gov or Sherry Ng at 6476-9349 or Sherry.Ng@mail.doc.gov